19-12897786-TG-TGG
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000222214.10(GCDH):c.1173dupG(p.Asn392fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,612,764 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000096 ( 0 hom. )
Consequence
GCDH
ENST00000222214.10 frameshift
ENST00000222214.10 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.579
Genes affected
GCDH (HGNC:4189): (glutaryl-CoA dehydrogenase) The protein encoded by this gene belongs to the acyl-CoA dehydrogenase family. It catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA and CO(2) in the degradative pathway of L-lysine, L-hydroxylysine, and L-tryptophan metabolism. It uses electron transfer flavoprotein as its electron acceptor. The enzyme exists in the mitochondrial matrix as a homotetramer of 45-kD subunits. Mutations in this gene result in the metabolic disorder glutaric aciduria type 1, which is also known as glutaric acidemia type I. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 12. [provided by RefSeq, Mar 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-12897786-T-TG is Pathogenic according to our data. Variant chr19-12897786-T-TG is described in ClinVar as [Likely_pathogenic]. Clinvar id is 555570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GCDH | NM_000159.4 | c.1173dupG | p.Asn392fs | frameshift_variant | 11/12 | ENST00000222214.10 | NP_000150.1 | |
GCDH | NM_013976.5 | c.1173dupG | p.Asn392fs | frameshift_variant | 11/12 | NP_039663.1 | ||
GCDH | NR_102316.1 | n.1336dupG | non_coding_transcript_exon_variant | 11/12 | ||||
GCDH | NR_102317.1 | n.1554dupG | non_coding_transcript_exon_variant | 10/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GCDH | ENST00000222214.10 | c.1173dupG | p.Asn392fs | frameshift_variant | 11/12 | 1 | NM_000159.4 | ENSP00000222214.4 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151518Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
4
AN:
151518
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461246Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 726984
GnomAD4 exome
AF:
AC:
14
AN:
1461246
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
726984
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151518Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 73962
GnomAD4 genome
AF:
AC:
4
AN:
151518
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
73962
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Glutaric aciduria, type 1 Pathogenic:4
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Dec 13, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 11, 2023 | This sequence change creates a premature translational stop signal (p.Asn392Glufs*5) in the GCDH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GCDH are known to be pathogenic (PMID: 10699052, 11854167, 16602100). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with glutaric acidemia (PMID: 25762492). ClinVar contains an entry for this variant (Variation ID: 555570). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Oct 27, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 24, 2024 | - - |
GCDH-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 05, 2024 | The GCDH c.1173dupG variant is predicted to result in a frameshift and premature protein termination (p.Asn392Glufs*5). This variant has been reported in individuals with glutaric acidemia 1, including in the homozygous state in three affected members of one family (Gupta et al. 2015. PubMed ID: 25762492; https://www.ejmanager.com/mnstemps/173/173-1495636462.pdf?t=1641228585). In addition, it has been reported along with a pathogenic GCDH variant in a study of individuals with motor, speech/language, cognitive, behavioral, or intellectual abnormalities (sample S0993 in Table S2, Dong et al. 2020. PubMed ID: 32005694). This variant is reported in 0.0033% of alleles in individuals of South Asian descent in gnomAD. Frameshift variants in GCDH are expected to be pathogenic. Taken together, this variant is interpreted as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at